Abstract
Transplanting umbilical-cord blood-stem cells might provide an improved alternative to bone-marrow transplants in childhood cancer patients, according to research conducted at the University of Texas Southwestern Medical Center, Dallas. Some 40 umbilical-cord blood-stem cell transplants have been performed worldwide since 1989, including Southwestern Medical Center9s first procedure, performed last November, by Eric Sandler, M.D., FAAP. Dr. Sandler is co-director of the hospital9s Umbilical Stem Cell Project. The project aims to procure, test and store human umbilical-cord and placental blood for use as an alternative to bone-marrow transplants. Cord blood is banked by human leukocyte antigen (HLA) types. Southwestern is one of five umbilical-cord blood banks in the United States, Dr. Sandler said.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
